Evaluation of medication compliance for secondary prevention of acute coronary syndrome

7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To prevent recurrence of acute coronary syndrome (ACS), national practice guidelines recommend use of five-drug combination therapy. Our study assessed the proportion of patients discharged on all five medications following ACS and determined reasons for nonadherence. A retrospective, single-center chart review was conducted at a tertiary academic medical center. Patients 18 years and older who were admitted to the cardiac care unit with a diagnosis of ACS between January 2013 and January 2015 were included. Overall, 200 patients were screened and 155 were included in the study. Half of the patients received all guideline-recommended classes of pharmacological agents at discharge. The other half-78 patients-did not receive the five-drug combination, of whom 48 (62%) had reasons documented for nonadherence. Our study’s findings suggest that rates of adherence need to improve given the clear benefits of these medications.

Cite

CITATION STYLE

APA

Gill, D., Feldman, E. A., & Liu, K. (2018). Evaluation of medication compliance for secondary prevention of acute coronary syndrome. Baylor University Medical Center Proceedings, 30(4), 410–415. https://doi.org/10.1080/08998280.2017.11930208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free